Mika Nishimura
Direktor/Vorstandsmitglied bei SI-BONE, INC.
Vermögen: 546 889 $ am 30.04.2024
Profil
Mika Nishimura is the founder of BLG Group.
She currently holds four positions as an independent director at SI-BONE, Inc., HOYA Corp., Accuray, Inc., and MobileODT Ltd.
Previously, she held positions as Director-Global Marketing at Guidant Vascular Intervention, VP-International Sales, Operations & Marketing at ev3, Inc., Vice President-Commercialization at nVision Medical Corp., and Vice President-Commercial Development at Auxogyn, Inc. She received her undergraduate degree from Yale University and her MBA from Harvard Business School.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ACCURAY INCORPORATED
0,16% | 30.11.2023 | 156 056 ( 0,16% ) | 340 202 $ | 30.04.2024 |
SI-BONE, INC.
0,04% | 31.03.2024 | 14 484 ( 0,04% ) | 206 687 $ | 30.04.2024 |
Aktive Positionen von Mika Nishimura
Unternehmen | Position | Beginn |
---|---|---|
SI-BONE, INC. | Direktor/Vorstandsmitglied | 04.03.2021 |
ACCURAY INCORPORATED | Direktor/Vorstandsmitglied | 17.08.2021 |
HOYA CORPORATION | Direktor/Vorstandsmitglied | 01.06.2022 |
BLG Group | Gründer | - |
MobileODT Ltd.
MobileODT Ltd. Packaged SoftwareTechnology Services MobileODT Ltd. develops optical diagnostic devices and software services focused on early cancer detection. It uses mobile phones to detect cancer and also develops point-of-care diagnostic solutions for the global market. The firm’s product EVA System, functions on its own as an enhanced visual assessment screening or alongside any cervical cancer treatment. The company was founded by Ariel Beery and David Levitz in October 2012 and is headquartered in Tel Aviv, Israel. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Mika Nishimura
Unternehmen | Position | Ende |
---|---|---|
nVision Medical Corp.
nVision Medical Corp. Hospital/Nursing ManagementHealth Services nVision Medical Corp. operates as a venture-backed medical device company. It develops a technology that can be used in the office of the gynecologist to diagnose the cause of infertility as well as ovarian cancer. The company was founded by Surbhi Sarna in January 2012 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01.01.2020 |
Auxogyn, Inc.
Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 01.01.2015 |
Guidant Vascular Intervention | Vertrieb & Marketing | - |
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Geschäftsführer | - |
Ausbildung von Mika Nishimura
Yale University | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
SI-BONE, INC. | Health Technology |
ACCURAY INCORPORATED | Health Technology |
HOYA CORPORATION | Health Technology |
Private Unternehmen | 6 |
---|---|
Auxogyn, Inc.
Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Health Technology |
ev3, Inc.
ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Health Technology |
Guidant Vascular Intervention | |
BLG Group | |
MobileODT Ltd.
MobileODT Ltd. Packaged SoftwareTechnology Services MobileODT Ltd. develops optical diagnostic devices and software services focused on early cancer detection. It uses mobile phones to detect cancer and also develops point-of-care diagnostic solutions for the global market. The firm’s product EVA System, functions on its own as an enhanced visual assessment screening or alongside any cervical cancer treatment. The company was founded by Ariel Beery and David Levitz in October 2012 and is headquartered in Tel Aviv, Israel. | Technology Services |
nVision Medical Corp.
nVision Medical Corp. Hospital/Nursing ManagementHealth Services nVision Medical Corp. operates as a venture-backed medical device company. It develops a technology that can be used in the office of the gynecologist to diagnose the cause of infertility as well as ovarian cancer. The company was founded by Surbhi Sarna in January 2012 and is headquartered in San Francisco, CA. | Health Services |